338 related articles for article (PubMed ID: 32827579)
1. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
[TBL] [Abstract][Full Text] [Related]
2. Recent Update on Targeting
Chaudhuri R; Bhattacharya S; Dash J; Bhattacharya S
J Med Chem; 2021 Jan; 64(1):42-70. PubMed ID: 33355454
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the equilibrium between G-quadruplex and duplex DNA in promoter of human c-myc oncogene by a pyrene derivative.
Zhang Z; He X; Yuan G
Int J Biol Macromol; 2011 Dec; 49(5):1173-6. PubMed ID: 21683090
[TBL] [Abstract][Full Text] [Related]
4. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
[TBL] [Abstract][Full Text] [Related]
5. Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression.
Felsenstein KM; Saunders LB; Simmons JK; Leon E; Calabrese DR; Zhang S; Michalowski A; Gareiss P; Mock BA; Schneekloth JS
ACS Chem Biol; 2016 Jan; 11(1):139-48. PubMed ID: 26462961
[TBL] [Abstract][Full Text] [Related]
6. The c-MYC NHE III(1): function and regulation.
González V; Hurley LH
Annu Rev Pharmacol Toxicol; 2010; 50():111-29. PubMed ID: 19922264
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein.
González V; Guo K; Hurley L; Sun D
J Biol Chem; 2009 Aug; 284(35):23622-35. PubMed ID: 19581307
[TBL] [Abstract][Full Text] [Related]
8. Ligand-induced conformational preorganization of loops of c-MYC G-quadruplex DNA and its implications in structure-specific drug design.
Harikrishna S; Kotaru S; Pradeepkumar PI
Mol Biosyst; 2017 Jul; 13(8):1458-1468. PubMed ID: 28650023
[TBL] [Abstract][Full Text] [Related]
9. Piperine analogs arrest c-myc gene leading to downregulation of transcription for targeting cancer.
Pandya N; Kumar A
Sci Rep; 2021 Nov; 11(1):22909. PubMed ID: 34824301
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a Family of Genomic Sequences Which Interact Specifically with the c-MYC Promoter to Regulate c-MYC Expression.
Rezzoug F; Thomas SD; Rouchka EC; Miller DM
PLoS One; 2016; 11(8):e0161588. PubMed ID: 27551915
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a fluorescent, long chain-bridged bispurine that selectively targets the c-MYC G-quadruplex.
Hu MH; Lin JH; Huang Q
Bioorg Chem; 2022 May; 122():105750. PubMed ID: 35325695
[TBL] [Abstract][Full Text] [Related]
12. In silico identification of novel ligands for G-quadruplex in the c-MYC promoter.
Kang HJ; Park HJ
J Comput Aided Mol Des; 2015 Apr; 29(4):339-48. PubMed ID: 25527072
[TBL] [Abstract][Full Text] [Related]
13. Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex.
Brown RV; Danford FL; Gokhale V; Hurley LH; Brooks TA
J Biol Chem; 2011 Nov; 286(47):41018-27. PubMed ID: 21956115
[TBL] [Abstract][Full Text] [Related]
14. Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex.
Calabrese DR; Chen X; Leon EC; Gaikwad SM; Phyo Z; Hewitt WM; Alden S; Hilimire TA; He F; Michalowski AM; Simmons JK; Saunders LB; Zhang S; Connors D; Walters KJ; Mock BA; Schneekloth JS
Nat Commun; 2018 Oct; 9(1):4229. PubMed ID: 30315240
[TBL] [Abstract][Full Text] [Related]
15. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
[TBL] [Abstract][Full Text] [Related]
16. Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics.
Chen BJ; Wu YL; Tanaka Y; Zhang W
Int J Biol Sci; 2014; 10(10):1084-96. PubMed ID: 25332683
[TBL] [Abstract][Full Text] [Related]
17. The flanking sequence contributes to the immobilisation of spermine at the G-quadruplex in the NHE (nuclease hypersensitivity element) III1 of the c-Myc promoter.
Keniry MA; Owen EA
FEBS Lett; 2014 May; 588(10):1949-54. PubMed ID: 24735723
[TBL] [Abstract][Full Text] [Related]
18. Quinazoline derivative QPB-15e stabilizes the c-myc promoter G-quadruplex and inhibits tumor growth in vivo.
Li Z; Liu C; Huang C; Meng X; Zhang L; He J; Li J
Oncotarget; 2016 Jun; 7(23):34266-76. PubMed ID: 27144522
[TBL] [Abstract][Full Text] [Related]
19. Resolving the Ligand-Binding Specificity in c-MYC G-Quadruplex DNA: Absolute Binding Free Energy Calculations and SPR Experiment.
Deng N; Wickstrom L; Cieplak P; Lin C; Yang D
J Phys Chem B; 2017 Nov; 121(46):10484-10497. PubMed ID: 29086571
[TBL] [Abstract][Full Text] [Related]
20. New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the
Hu MH; Lin JH
J Med Chem; 2021 May; 64(10):6720-6729. PubMed ID: 33961424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
